Carlos Buitrago Tellez

Carlos Buitrago Tellez

Auto-generated profile, based on publicly available information

Carlos Buitrago Tellez

Institut für Medizinische Radiologie (IMR) Bürgerspital Solothurn, Solothurn, Switzerland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2024 in Neurology
Verified
Journal Article
Open access
MGMartina B. Goeldlin
Martina B. Goeldlin
MMMadlaine Müller
Madlaine Müller
BSBernhard M. Siepen
Bernhard M. Siepen
WZWenpeng Zhang
Wenpeng Zhang
HOHatice Ozkan
Hatice Ozkan
FIfor Swiss Stroke Registry Investigators and SIGNAL Investigators
for Swiss Stroke Registry Investigators and SIGNAL Investigators
Cerebral small vessel disease (SVD) is the major cause of intracerebral hemorrhage (ICH). There is no comprehensive, easily applicable classification of ICH subtypes according to the presumed underlying SVD using MRI. We developed an MRI-based classification for SVD-related ICH. We performed a retrospective study in the prospectively collected Swiss Stroke Registry (SSR, 2013-2019) and the Stroke InvestiGation in North And central London (SIGNAL) cohort. Patients with nontraumatic, SVD-related ICH and available MRI within 3 months were classified as Cerebral Amyloid angiopathy (CAA), Deep perforator arteriopathy (DPA), Mixed CAA-DPA, or Undetermined SVD using hemorrhagic and nonhemorrhagic MRI markers (CADMUS classification). The primary outcome was inter-rater reliability using Gwet's AC1. Secondary outcomes were recurrent ICH/ischemic stroke at 3 months according to the CADMUS phenotype. We performed Firth penalized logistic regressions and competing risk analyses. The SSR cohort included 1,180 patients (median age [interquartile range] 73 [62-80] years, baseline NIH Stroke Scale 6 [2-12], 45.6% lobar hematoma, systolic blood pressure on admission 166 [145-185] mm Hg). The CADMUS phenotypes were as follows: mixed CAA-DPA (n = 751 patients, 63.6%), undetermined SVD (n = 203, 17.2%), CAA (n = 154, 13.1%), and DPA (n = 72, 6.3%), with a similar distribution in the SIGNAL cohort (n = 313). Inter-rater reliability was good (Gwet's AC1 for SSR/SIGNAL 0.69/0.74). During follow-up, 56 patients had 57 events (28 ICH, 29 ischemic strokes). Three-month event rates were comparable between the CADMUS phenotypes. CADMUS, a novel MRI-based classification for SVD-associated ICH, is feasible and reproducible and may improve the classification of ICH subtypes in clinical practice and research.

30 March 2024 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
NMNando Mertineit
Nando Mertineit
CTCarlos Buitrago Tellez
Carlos Buitrago Tellez
PKPascal Kissling
Pascal Kissling
FMFrank Mosler
Frank Mosler
JHJohannes Heverhagen
Johannes Heverhagen
GNGerd Nöldge
Gerd Nöldge
The therapy of pelvic aneurysms is minimally invasive through interventional radiology using various devices and embolic agents: 1. By using a covered stent/prosthesis to maintain antegrade flow when a landing zone, i.e., a vascular segment angiographically present into which the stent can be placed to bridge the neck of the aneurysm, thereby interrupting aneurysm perfusion. 2. Through complete embolization of the aneurysm using embolic agents/coils. 3. As performed in our case, by covering the aneurysm (Img 14 A-C) with a covered stent /prosthesis, following prior embolization of the branching vessels using macroembolic agents. In cases where there is insufficient occlusion of the aneurysm with residual perfusion, secondary em- bolization becomes considerably more complex due to the occlusion of the anatomically antegrade access and the altered hemodynamics around the aneurysm causing retrograde collateralization. Through detailed analysis of CT angiography, even in static CT, retrograde circulation could be iden- tified, allowing for a minimally invasive secondary approach to the aneurysm without the need for general anesthesia and/or surgery. By completely eliminating the aneurysm, the risk of rupture in the elderly patient was minimally invasively eliminated. The treatment of this patient exemplifies the possibilities that embolization with a wide array of embolic agents and catheters offers in a hemo- dynamically very complex situation.

31 January 2024 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
NMNando Mertineit
Nando Mertineit
CTCarlos Buitrago Tellez
Carlos Buitrago Tellez
PKPascal Kissling
Pascal Kissling
FMFrank Mosler
Frank Mosler
GNGerd Nöldge
Gerd Nöldge
The management of an aneurysm or pseudoaneurysm, including decisions regarding how, when, and with what method it should be treated, must always be determined through interdisciplinary consensus grounded in a thorough understanding of the existing literature. Consequently, today's preferred approach is embolization therapy or covered stenting. This method, performed in a minimally invasive manner, has been well-established due to its methodical low invasiveness and high effectiveness in achieving both technical and clinical success. It stands as a prominent choice among the available surgical and minimally invasive therapy options. The procedure, executed with advanced technology, utilizes the latest catheters and wires, coupled with expertise in various embolization methods. This comprehensive approach enables the treatment of acute bleeding in emergency cases, ensuring a nuanced and effective response (9-13).

30 July 2024 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
NMNando Mertineit
Nando Mertineit
AMAmgad El Mekabaty
Amgad El Mekabaty
GAGholam Reza Afarideh
Gholam Reza Afarideh
CTCarlos Buitrago Tellez
Carlos Buitrago Tellez
PKPascal Kissling
Pascal Kissling
GNGerd Nöldge
Gerd Nöldge
The first lienal artery aneurysm was discovered and described for the first time in 1770 by the Frenchman Beaussier during an autopsy. It was first visualised using X-rays in 1920 by the physicians Akbulut and Otan. The first surgical treatment of a splenic artery aneurysm was performed by sur-geons MacLeod and Maurice in 1940. The first minimally invasive endovascular therapies using coils, stents or a combination of the two devices for minimally invasive treatment of aneurysms of the lienal artery were reported in 1990, 1994 and 1995 (1,2,3). 63-year-old patient with a known aneurysmal arteriopathy of the thoracic aorta in the sense of an aortic dissection in coexistence with a 2.2 cm splenic artery aneurysm discovered by chance in the vascular surgery department of the Bürgerspital Solothurn. The interdisciplinary consensus primarily favoured vascular surgery or minimally invasive transcatheter treatment to eliminate the splenic artery aneurysm. The dissected thoracic aortic aneurysm detected in the pre-interventional CT of the thorax and abdomen, extending into the abdominal aorta, (Fig. 1) should only be treated with minimally invasive endovascular treatment using EVAR after stenting of the lienal artery aneurysm detected by CT (Fig. 9, 10, 11). A reverse therapeutic sequence would have allowed access to the lienal artery aneurysm only by fenestration of the EVAR. For the treatment of our patient's wide-neck aneurysm, the use of a Viabahn was chosen from the many known and proven occlusion materials as a significantly less invasive alternative to surgical treatment of the aneurysm by interdisciplinary consensus. Due to a technical complication during the deployment of the first vial, a two-stage angiographic therapeutic intervention was necessary.